BHVN Q1 2021 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+3707.4% YoY

Gross Profit

$31M70.7% margin

Operating Income

-$236M-537.8% margin

Net Income

-$265M-604.6% margin

EPS (Diluted)

$-4.27

QoQ Revenue Growth

+24.8%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$1.2B

Stockholders' Equity

$77M

Cash & Equivalents

-$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$1M	+3707.4%
Gross Profit	$31M	$727,000	+4158.7%
Operating Income	-$236M	-$151M	-56.1%
Net Income	-$265M	-$173M	-53.2%